BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit

PR Newswire

LOS ANGELES, Sept. 22, 2023

LOS ANGELES, Sept. 22, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC).

Class Period: August 6, 2020 – May 3, 2023
Lead Plaintiff Deadline: September 25, 2023

If you wish to serve as lead plaintiff of the Bausch lawsuit, you can submit your contact information at www.glancylaw.com/cases/Bausch-Health-Companies-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) the B+L spinoff would not result in two strong separate companies; (2) without B+L, Bausch was left overly leveraged and without the cashflow generated by B+L; (3) distribution of the B+L spinoff shares would not occur as represented; (4) the above statements omitted and/or concealed the potential damages Bausch faced from the Opt-Out Plaintiffs; (5) the spinoff was not intended to benefit Bausch shareholders but instead designed to subvert the Opt-Out Plaintiffs' lawsuit against the company; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bhc-investors-have-opportunity-to-lead-bausch-health-companies-inc-securities-fraud-lawsuit-301936452.html

SOURCE Glancy Prongay & Murray LLP

You are here

BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit

BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit